NICOLE WYDRA: Open Payments
NPI 1962514836 · CORVALLIS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 67 payments from 15 companies in 2025. Trend: 2023 $1,791 · 2024 $2,001 · 2025 $1,325
Food & beverage: $1,325
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $436 |
| Lilly USA, LLC | 7 | $169 |
| GENZYME CORPORATION | 6 | $159 |
| Janssen Biotech, Inc. | 9 | $157 |
| PFIZER INC. | 3 | $71 |
| UCB, Inc. | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
| Galderma Laboratories, L.P. | 1 | $24 |
Products named: RINVOQ, SKYRIZI, DUPIXENT, TREMFYA, TALTZ, CIBINQO, Bimzelx, EBGLYSS.
Industry payments across OR — which companies pay providers there.
